Skip to main content
logo
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.08
-0.45 (-3.10%)
Apr 16, 2026, 4:00 PM EDT - Market closed

Adaptive Biotechnologies Operating Metrics

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Number of Clonoseq Tests Delivered
96.49K88.98K82.18K76.11K70.84K66.31K61.46K56.50K
Number of Clonoseq Tests Delivered Growth
36.21%34.19%33.72%34.71%37.98%44.41%48.98%53.23%

Revenue by Segment

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
MRD
190.60M171.28M156.62M145.53M136.14M123.34M113.94M102.74M
MRD Growth
40.00%38.87%37.46%41.65%36.03%29.33%25.53%17.90%
Immune Medicine
62.16M33.94M32.90M33.43M41.14M45.43M60.56M67.54M
Immune Medicine Growth
51.09%-25.29%-45.67%-50.50%-48.32%-51.79%-35.27%-31.20%

Immune Medicine Revenue Breakdown

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Collaboration
44.78M14.55M12.36M13.45M17.87M22.37M38.15M42.58M
Collaboration Growth
150.58%-34.98%-67.59%-68.41%-64.93%-65.19%-38.27%-35.86%
Immune Medicine Service
17.38M19.39M20.54M19.98M23.27M23.06M22.42M24.96M
Immune Medicine Service Growth
-25.31%-15.89%-8.37%-19.96%-18.79%-23.09%-29.43%-21.46%

Adjusted EBITDA by Segment

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024
Immune
5.36M-23.56M-24.52M-26.01M
MRD
-1.79M-14.87M-28.08M-41.22M

MRD Revenue Breakdown

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Service
174.10M156.28M144.12M133.03M123.64M115.84M109.44M102.74M
Service Growth
40.81%34.91%31.69%29.48%26.06%24.07%24.69%26.61%
Regulatory Milestone
16.50M15.00M12.50M-12.50M7.50M4.50M-
Regulatory Milestone Growth
32.00%100.00%177.78%-----
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.